Found: 7
Select item for more details and to access through your institution.
A potent SARS-CoV-2 neutralising nanobody shows therapeutic efficacy in the Syrian golden hamster model of COVID-19.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25480-z
- By:
- Publication type:
- Article
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
- Published in:
- Nature Protocols, 2021, v. 16, n. 6, p. 3114, doi. 10.1038/s41596-021-00536-y
- By:
- Publication type:
- Article
Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21389-9
- By:
- Publication type:
- Article
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.
- Published in:
- 2021
- By:
- Publication type:
- Journal Article
Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20439-y
- By:
- Publication type:
- Article
A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-18058-8
- By:
- Publication type:
- Article
A Novel Vaccine against Crimean-Congo Haemorrhagic Fever Protects 100% of Animals against Lethal Challenge in a Mouse Model.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091516
- By:
- Publication type:
- Article